Reply to E. Hindié and A.K. Goel et al

J Clin Oncol. 2019 Oct 10;37(29):2705-2707. doi: 10.1200/JCO.19.01860. Epub 2019 Aug 29.

Authors

Johannes Holtschmidt¹, Sherko Kuemmel¹, David Krug¹, Elisabeth Breit¹, Thorsten Kuehn¹, Mattea Reinisch¹

Affiliation

¹ Johannes Holtschmidt, MD, Kliniken Essen-Mitte, Essen, Germany, and University of Cologne, Cologne, Germany; Sherko Kuemmel, PhD, Kliniken Essen-Mitte, Essen, Germany; David Krug, MD, University Hospital Schleswig-Holstein, Kiel, Germany; Elisabeth Breit, PhD, Kliniken Essen-Mitte, Essen, Germany; Thorsten Kuehn, PhD, Clinic Esslingen, Esslingen, Germany; and Mattea Reinisch, MD, Kliniken Essen-Mitte, Essen, Germany.

PMID: 31465263
DOI: 10.1200/JCO.19.01860

No abstract available

Publication types

Comment

MeSH terms

Breast Neoplasms*
Humans
Lymphoscintigraphy*
Prospective Studies
Rare Diseases
Sentinel Lymph Node Biopsy